Grants for Native American tribal organizations - Health

This funding opportunity supports researchers in developing innovative resources and technologies to improve the reliability and applicability of animal models in biomedical research, with a focus on projects that address broad health issues and involve multiple NIH Institutes.

This funding opportunity supports research on how diet and lipid metabolism influence tumor growth and progression, targeting higher education institutions, nonprofits, and certain for-profit organizations with expertise in nutrition science.

This funding opportunity provides financial support to various organizations to enhance Indonesia's public health systems and capacity through collaboration with the Ministry of Health, focusing on critical areas like surveillance, laboratory systems, and emergency response.

This grant provides funding for researchers to develop and validate innovative, safe, and noninvasive methods for real-time assessment of placenta development and function throughout pregnancy, ultimately aiming to improve maternal and fetal health outcomes.

The Outdoor Equity Fund aims to enhance safe, equitable access to outdoor spaces and nature-based learning for Wabanaki, Black, Indigenous, and People of Color (BIPOC) in Maine, unceded land of the Wabanaki. The fund addresses systemic barriers that BIPOC communities face in accessing outdoor spaces by supporting organizations working on land-based cultural preservation, land-back projects, leadership development, farming and gardening programs, outdoor accessibility, expeditions, learning, and therapeutic programs. It operates with a Community Advisory Committee guiding its efforts and employs a participatory grantmaking process. Selected organizations for the 2023 cohort will receive $30,000 over three years for general operating support, alongside opportunities for peer learning and capacity-building activities.

Reissue PAR-19-220.

This program provides funding to early-career researchers who have received specific NIDDK K awards, enabling them to conduct small-scale research projects that will help them transition to independent investigator roles.

This grant provides funding for innovative research projects aimed at improving mental health services and access for underserved populations, focusing on non-clinical trial methodologies.

This grant provides funding to various organizations in Indiana to promote digital equity and improve access to technology for underserved populations, including low-income households, seniors, veterans, and rural residents.

This funding opportunity supports early-career clinical scientists from diverse backgrounds in developing their research skills and addressing cancer health disparities through mentored research experiences in cancer-related fields.

This funding opportunity provides financial support to organizations working in Tanzania to improve HIV prevention and treatment services, strengthen local health systems, and promote health equity for people living with HIV.

This grant provides funding to support advanced students and postdoctoral researchers in neuroscience, helping them gain the skills needed to translate basic research into clinical applications for neurological diseases.

This funding opportunity supports research projects that evaluate and improve crisis response services for suicide prevention, targeting a wide range of eligible applicants including universities, nonprofits, and government entities.

This funding opportunity supports research projects that include clinical trials aimed at improving health outcomes, targeting a wide range of eligible applicants such as universities, nonprofits, and for-profit organizations.

This grant provides funding for short courses that aim to enhance research skills in using cognitive data to study aging and Alzheimer's disease across different countries, ultimately improving health outcomes and informing policies.

The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collaborating on a single set of integrated specific aims, culminating in data on optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of other critical knowledge and methods for interpretation of such a trial, such as clinical assessment of the engagement of an outcome-relevant target. Enhancing workforce and institutional capacity to conduct future rigorous, transdisciplinary research on chemically complex natural products must be built into the plans for research and for enhancing diverse perspectives. Achievement of the RM1 specific aims is expected to provide a strong foundation for a future highly informative clinical efficacy trial of the effects on resilience of a chemically complex natural product.This NOFO is one component of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include RFA-AT-24-008, Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01) and RFA-AT-24-007, Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).

The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening.

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), theNCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in community cancer prevention, intervention, and treatment research. Special emphasis is placed on training of clinical scientists whose career goal is to meet the needs of underserved or underrepresent ed communities for access to clinical care and participation in clinical research. The NOFO will allow the appointment ofScholars proposing to serve as the lead investigator of an independent community-based clinical trial; or proposing a separate ancillary study to an existing prevention, screening or control clinical trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of underserved or underrepresented communitiesin cancer clinical research, as part of their research and career development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is expected to be published in April 2024 with an expected application due date in June 2024. TheNOFO will utilize theK12 activity code for Clinical Scientist Institutional Career Development Program Awards. Details of the planned NOFO are provided below.

This funding opportunity is designed to strengthen health informatics capabilities in PEPFAR-supported countries by developing a skilled workforce and enhancing digital health systems to combat HIV/AIDS and tuberculosis effectively.

This funding opportunity supports higher education institutions, nonprofit organizations, for-profit organizations, and local governments in establishing a Coordinating Center to implement and evaluate population genomic screening in primary care, focusing on diverse communities and actionable genetic conditions.